Merck & Co (NYSE:MRK) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.27) by 51.85 percent. This is a 106.1 percent decrease over earnings of $2.13 per share from the same period last year. The company reported quarterly sales of $16.607 billion which beat the analyst consensus estimate of $16.356 billion by 1.54 percent. This is a 5.07 percent increase over sales of $15.806 billion the same period last year.